Circulating monocytes from healthy individuals and COPD patients

[1]  P. Renard,et al.  The proinflammatory transcription factor NFκB: a potential target for novel therapeutical strategies , 2004, Cell Biology and Toxicology.

[2]  P. Barnes,et al.  Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4. , 2003, Chest.

[3]  R. Buhl,et al.  Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD. , 2003, Chest.

[4]  I. Ginsburg.  The role of bacteriolysis in the pathophysiology of inflammation, infection and post‐infectious sequelae , 2002, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[5]  P. Barnes,et al.  Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[6]  Timothy Ravasi,et al.  The mononuclear phagocyte system revisited , 2002, Journal of leukocyte biology.

[7]  N. Siafakas,et al.  Few smokers develop COPD. Why? , 2002, Respiratory medicine.

[8]  R. Stockley,et al.  Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of α1–antitrypsin deficiency and the role of leukotriene B4 and interleukin 8 , 2002, Thorax.

[9]  P. Barnes,et al.  Increased levels of the chemokines GROα and MCP-1 in sputum samples from patients with COPD , 2002, Thorax.

[10]  R. Stockley.  Neutrophils and the pathogenesis of COPD. , 2002, Chest.

[11]  D. Mannino.  COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. , 2002, Chest.

[12]  G. Stark,et al.  NFκB-dependent signaling pathways , 2002 .

[13]  G. Stark,et al.  NFkappaB-dependent signaling pathways. , 2002, Experimental hematology.

[14]  D. Postma,et al.  Chronic obstructive pulmonary disease. , 2002, Clinical evidence.

[15]  W. Seeger,et al.  Molecular pathways of monocyte emigration into the alveolar air space of intact mice. , 2002, American journal of respiratory and critical care medicine.

[16]  S. Lindgren,et al.  C-terminal fragment of alpha1-antitrypsin activates human monocytes to a pro-inflammatory state through interactions with the CD36 scavenger receptor and LDL receptor. , 2001, Atherosclerosis.

[17]  K. Chung,et al.  Cytokines in chronic obstructive pulmonary disease , 2001, European Respiratory Journal.

[18]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[19]  S. Shapiro,et al.  Matrix metalloproteinases in lung biology , 2000, Respiratory research.

[20]  A. Sandford,et al.  Genetic risk factors for chronic obstructive pulmonary disease. , 2002, Clinics in chest medicine.

[21]  R. Roth,et al.  Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. , 2000, Pharmacological reviews.

[22]  W. Dichtl,et al.  The carboxyl-terminal fragment of alpha1-antitrypsin is present in atherosclerotic plaques and regulates inflammatory transcription factors in primary human monocytes. , 2000, Molecular cell biology research communications : MCBRC.

[23]  J. Nadel.  Role of neutrophil elastase in hypersecretion during COPD exacerbations, and proposed therapies. , 2000, Chest.

[24]  G. Viegi,et al.  Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. , 2000, Chest.

[25]  N. Soehendra,et al.  Role of transesophageal endosonography-guided fine-needle aspiration in the diagnosis of lung cancer. , 2000, Chest.

[26]  R. Stockley,et al.  Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ). , 1999, American journal of respiratory and critical care medicine.

[27]  S. Shapiro,et al.  The macrophage in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[28]  W. Maziak,et al.  Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[29]  C. Cross,et al.  Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease? , 1999, American journal of respiratory and critical care medicine.

[30]  M. Peters-Golden,et al.  Regulation of 5-lipoxygenase metabolism in mononuclear phagocytes by CD4 T lymphocytes. , 1999, Experimental lung research.

[31]  M. D. de Santi,et al.  Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitor-deficient mice. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[32]  C. Marsh,et al.  Monocyte Fc gamma receptor cross-linking induces IL-8 production. , 1995, Journal of immunology.

[33]  S. Shapiro,et al.  Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease. , 1994, American journal of respiratory and critical care medicine.

[34]  R. Crystal,et al.  Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. , 1991, The Journal of clinical investigation.

[35]  C. Corrigan,et al.  The roles of inflammatory cells in the pathogenesis of asthma and of chronic obstructive pulmonary disease. , 1991, The American review of respiratory disease.

[36]  R. Carrell,et al.  SMOKING, LUNG FUNCTION, AND α1-ANTITRYPSIN DEFICIENCY , 1985, The Lancet.

[37]  E. Berglund.  The pathophysiology of chronic respiratory failure. , 1970, Scandinavian journal of respiratory diseases. Supplementum.